DrugsControl Media Services
DrugsControl.org

News Detail

NPPA reduces prices of antibiotics manufactured by Cipla and Wockhardt as compound went off-patent (05-01-2024)

New Delhi, 5 Jan 2024: The National Pharmaceutical Pricing Authority (NPPA) has revised the retail prices of antibiotic drug ceftazidime pentahydrate manufactured by drug majors Cipla and Wockhardt significantly downwards after it has come to know that it contains a compound that......
View Details

Source : Pharmabiz
National Pharmaceutical Pricing Authority NPPA antibiotic drug ceftazidime pentahydrate Cipla Wockhardt methodology Pfizer Zavicefta Samarth Life Sciences ceftazidime pentahydrate avibactam Pharmatrac Wockhardt DPCO 2013

Related News